Elinzanetant
Stock Recap #PipelineProspector

Pipeline Prospector May 2024: J&J inks two deals for eczema drugs; Novo scores trial wins in hemophilia, kidney disease

Pharma indices have rebounded after ending March and April in the red. May saw the Nasdaq Biotechnol